Labroots Biotech & Pharma Sciences
LightNews LightNews
banner
biotech-lr.bsky.social
Labroots Biotech & Pharma Sciences
@biotech-lr.bsky.social
8 followers 1 following 67 posts
The Official @labroots.bsky.social Biotech & Pharma Page! Here for facts, events, videos, papers, and much more.
Posts Replies Media Videos
biotech-lr.bsky.social
Struggling with iPSC culture consistency? Discover a semi-automated workflow for stem cell selection, live-cell monitoring, and 3D spheroid generation that helps reduce variability and support robust advanced cell model development. Download the app note: buff.ly/yh7hbWY
Semi-Automated iPSC Culture and 3D Cell Model Generation
www.labroots.com
September 16, 2026 at 5:07 PM
biotech-lr.bsky.social
Modernizing a pharma QA/QC laboratory is about more than replacing a LIMS. Discover how to reduce complexity, standardize processes, prepare for AI and emerging technologies, and build a foundation for long-term value in this new practical guide. buff.ly/GK5j4HW
Modernizing pharmaceutical QA/QC laboratories
www.labroots.com
September 15, 2026 at 3:56 PM
biotech-lr.bsky.social
Novo Nordisk’s Wegovy helped 40.4% of children with obesity fall below the clinical obesity threshold after 68 weeks in a phase 3 trial.
buff.ly/4FPmuQJ
https://www.labroots.com/trending/biotech-and-pharma/31042/wegovy-promise-children-obesity
www.labroots.com
September 11, 2026 at 4:11 PM
biotech-lr.bsky.social
FDA expands Bayer’s Hyrnuo approval to first-line treatment for HER2-mutated NSCLC, after the drug showed a 75% response rate in previously untreated patients. buff.ly/lRXt0XI
https://www.labroots.com/trending/biotech-and-pharma/31041/fda-expands-hyrnuo-her2-mutated-lung-cancer
www.labroots.com
September 11, 2026 at 2:23 PM
biotech-lr.bsky.social
Antihistamines may offer little meaningful relief for eczema, while some may increase sedation and cognitive impairment. buff.ly/s9w7miz
https://www.labroots.com/trending/health-sciences-and-medical-research/31034/antihistamines-offer-little-relief-eczema
www.labroots.com
September 10, 2026 at 12:07 PM
biotech-lr.bsky.social
Tadalafil (Cialis) was associated with a higher risk of glaucoma and ocular hypertension in men, according to new research. buff.ly/6oEMECh
https://www.labroots.com/trending/drug-discovery/31024/cialis-linked-glaucoma-risk
www.labroots.com
September 9, 2026 at 2:52 PM
biotech-lr.bsky.social
Semaglutide was linked to nearly 40% fewer asthma attacks and 20% fewer COPD flare-ups in a large real-world study. buff.ly/bloTXEL
https://www.labroots.com/trending/drug-discovery/31023/semaglutide-linked-fewer-asthma-attacks
www.labroots.com
September 9, 2026 at 1:06 PM
biotech-lr.bsky.social
Learn how to advance your upstream strategy with expert insights from the BioPro Materials Virtual Summit, hosted by Thermo Fisher Scientific. Explore cell culture optimization, process intensification, scale-up, and more. September 29.
Register: www.labroots.com/ms/virtual-e...
September 8, 2026 at 4:30 PM
biotech-lr.bsky.social
The FDA has approved Gilead’s Bixlenvo, a new once-daily combination pill for adults with virologically suppressed HIV. The treatment combines bictegravir and lenacapavir. www.labroots.com/trending/bio...
https://www.labroots.com/trending/biotech-and-pharma/30975/fda-approves-gilead-s-once-daily-hiv-pill-bixlenvo
www.labroots.com
August 31, 2026 at 5:22 PM
biotech-lr.bsky.social
The FDA has approved Lisraya, the first targeted therapy for adults with dermatomyositis. www.labroots.com/trending/bio...
https://www.labroots.com/trending/biotech-and-pharma/30977/fda-approves-targeted-therapy-rare-skin-disease
www.labroots.com
August 28, 2026 at 6:13 PM
biotech-lr.bsky.social
The FDA approved Pasatru to significantly reduce abnormal bone formation in adults with the rare genetic disorder FOP. www.labroots.com/trending/bio...
FDA Approves Pasatru for Rare Bone-Forming Disorder | Biotech And Pharma
The FDA has approved Regeneron's Pasatru to reduce the formation of new abnormal bone and clinician-assessed flare-ups in adults with FOP. | Biotech And Pharma
www.labroots.com
August 24, 2026 at 9:07 PM
biotech-lr.bsky.social
Obsidian Therapeutics merged with Galera Therapeutics, securing $350 million to advance its engineered cell therapy pipeline through 2028. www.labroots.com/trending/bio...
Obsidian Therapeutics Merges with Galera Therapeutics | Biotech And Pharma
The clinical-stage biopharmaceutical company Obsidian Therapeutics finalized a transaction that brings Galera Therapeutics under the Obsidian name. Before | Biotech And Pharma
www.labroots.com
August 20, 2026 at 7:54 PM
biotech-lr.bsky.social
A common class of blood pressure medications is linked to a 33% higher risk of serious kidney complications in people with type 2 diabetes. www.labroots.com/trending/dru...
Blood Pressure Drugs Linked to Kidney Risk in Diabetes | Drug Discovery
A commonly prescribed group of blood pressure drugs has been associated with a higher risk of serious kidney problems in people with type 2 diabetes. | Drug Discovery
www.labroots.com
August 20, 2026 at 7:53 PM
biotech-lr.bsky.social
In a 36-week trial, the experimental daily pill aleniglipron helped adults with obesity or overweight achieve up to 12.1% body weight loss. www.labroots.com/trending/dru...
Pill-Based GLP-1 Drug Cuts Weight by Up to 12.1% | Drug Discovery
Aleniglipron helped adults with obesity or overweight lose up to 12.1% of their body weight over 36 weeks. | Drug Discovery
www.labroots.com
August 17, 2026 at 8:55 PM
biotech-lr.bsky.social
Researchers combined generative AI with microbiome analysis to identify 43 key genes tied to Crohn's bowel scarring, enabling earlier detection of tissue damage. www.labroots.com/trending/bio...
Generative AI Helps Spot Crohn's Bowel Scarring Early | Biotech And Pharma
How can generative AI be used to identify and diagnose Crohn’s disease? This is what a recent study published in Frontiers in Artificial Intelligence | Biotech And Pharma
www.labroots.com
August 17, 2026 at 8:55 PM
Reposted by Labroots Biotech & Pharma Sciences
labroots.bsky.social
Please be sure to check out our myriad of category pages...

ScienceRocks @sciencedoesrock.bsky.social
Genetics @genetics-lr.bsky.social
Cell & Molecular Biology @cellbiology-lr.bsky.social
Immunology & Lymphatic System @immunology-lr.bsky.social
Cancer Research @cancer-lr.bsky.social
(1/n)
August 3, 2026 at 8:16 PM
Reposted by Labroots Biotech & Pharma Sciences
labroots.bsky.social
Cardiology & Circulatory System @cardiology-lr.bsky.social
Space & Astronomy @space-lr.bsky.social
Health Sciences & Medical Research @healthandmed-lr.bsky.social
Technology & Engineering @technology-lr.bsky.social
Chemistry & Physics @chemandphys-lr.bsky.social
(2/n)
August 3, 2026 at 8:16 PM
Reposted by Labroots Biotech & Pharma Sciences
labroots.bsky.social
Biotech & Pharma Sciences @biotech-lr.bsky.social
Drug Discovery @drugdiscovery-lr.bsky.social
Neuroscience & Nervous System @neuroscience-lr.bsky.social
Microbiology @microbiology-lr.bsky.social
Nature @nature-lr.bsky.social
Earth & Environmental Sciences @earth-lr.bsky.social
(3/n)
August 3, 2026 at 8:16 PM
Reposted by Labroots Biotech & Pharma Sciences
labroots.bsky.social
Diagnostics & Laboratory Medicine @diagnostics-lr.bsky.social
(4/n)
August 3, 2026 at 8:16 PM
biotech-lr.bsky.social
THC aids weight loss, but only full cannabis extract restores the signaling vital for blood-sugar regulation. buff.ly/swsk6G8
Beyond THC: Full Cannabis Extract Improves Glucose Levels | Biotech And Pharma
Multiple compounds in cannabis seem to play a key role in regulating glucose metabolism. | Biotech And Pharma
buff.ly
August 3, 2026 at 8:05 PM
biotech-lr.bsky.social
Engineers developed sweat-proof wearable sensors that maintain reliable health tracking even during heavy perspiration. www.labroots.com/trending/bio...
Sweat-Proof Wearable Sensors Offer Better Health Tracking | Biotech And Pharma
How can wearable biosensors be improved to maintain skin contact while still delivering essential health data? This is what a recent study published in Sci | Biotech And Pharma
www.labroots.com
July 31, 2026 at 10:08 PM
biotech-lr.bsky.social
Commercial cannabis markets are linked with higher consumption, not tightly controlled or decriminalised systems. www.labroots.com/trending/can...
Decriminalizing Cannabis Doesn't Increase Cannabis Use | Biotech And Pharma
New research found that decriminalizing personal use of cannabis and tightly controlling the legalization of cannabis don't increase use. | Biotech And Pharma
www.labroots.com
July 30, 2026 at 8:42 PM
biotech-lr.bsky.social
Newer small-molecule GLP-1 drugs may curb pleasure-driven eating—not just hunger. www.labroots.com/trending/dru...
Ozempic in a Pill? Oral GLP-1 Drugs Show Promise in Mice | Drug Discovery
Newer oral drugs related to Ozempic reduce pleasure-driven eating in mice. | Drug Discovery
www.labroots.com
July 30, 2026 at 8:41 PM
biotech-lr.bsky.social
In a mouse model of Alzheimer's disease, inhaled CBD reduced brain inflammation and improved memory-related performance. www.labroots.com/trending/can...
CBD Shows Early Promise for Alzheimer's | Biotech And Pharma
Cannabidiol (CBD) has been shown to reduce brain inflammation in a mouse model of Alzheimer's disease. | Biotech And Pharma
www.labroots.com
July 27, 2026 at 7:59 PM
biotech-lr.bsky.social
Commercial cannabis markets are linked with higher consumption, not tightly controlled or decriminalised systems. www.labroots.com/trending/can...
Decriminalizing Cannabis Doesn't Increase Cannabis Use | Biotech And Pharma
New research found that decriminalizing personal use of cannabis and tightly controlling the legalization of cannabis don't increase use. | Biotech And Pharma
www.labroots.com
July 27, 2026 at 7:59 PM